Cyclobenzaprine Hydrochloride
Product Images NDC 50436-0006

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 50436-0006). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (0e15dbb2 Figure 01)

Image (0e15dbb2 Figure 01)
Chemical structure of Cyclobenzaprine Hydrochloride showing the molecular framework including aromatic rings and the hydrochloride group. The diagram displays the arrangement of atoms and bonds in the active ingredient.*
FDA Label Image

Label Image (Lbl504360006)

Label Image (Lbl504360006)
Packaging label for Cyclobenzaprine Hydrochloride 5 mg tablets, containing 30 tablets per package. The label indicates the active ingredient as Cyclobenzaprine Hydrochloride USP, each tablet providing 5 mg. The product is manufactured by VKV-Tech, Inc. located in Newtown, PA, and labeled by Unit Dose Services, LLC in Dania, FL. Storage instructions advise keeping the product out of reach of children, in a well-closed container at room temperature (59°F to 77°F). The label includes warnings, lot number, expiration date fields, and a QR code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.